Dr Venner completed his medical training at the University of Calgary and later attended the University of British Columbia to complete a specialty degree in Hematology. He then went on to become the inaugural Plasma Cell Dyscrasias Fellow, a position funded jointly through the Leukemia/Bone Marrow Transplant Program of British Columbia, St. Bartholomew’s, and the London School of Medicine. After spending a year completing his fellowship training in the UK, he joined the National Amyloid Centre as a staff physician before returning to Edmonton and the Cross Cancer Institute (CCI). He is currently the clinical lead for the Malignant Hematology Program at the CCI. In addition to being actively involved in hematology clinical trials, his current academic interest involves clinical research in plasma cell dyscrasias. He is examining the evolution of therapy in these diseases as well as the impact novel combinations have had on survival.